Drug company drops case after EMA agrees to redactions in some documents to be publishedBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2632 (Published 07 April 2014) Cite this as: BMJ 2014;348:g2632
- Clare Dyer
AbbVie, one of two US drug companies that took legal action against the European Medicines Agency to try to stop it releasing previously secret clinical trial data, has dropped its lawsuits after agreeing that the documents may be disclosed with redactions to protect commercially sensitive information.
The London based drug regulator began a transparency initiative in 2010, resolving to disclose, on request, clinical study reports on drugs that had gone through the approval process. The policy saw it release nearly two million pages of data without legal challenge, but the process …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial